title: Acute lymphoblastic leukaemia with an e1a3 BCR-ABL1 fusion.
authors.affiliation: Cancer Molecular Diagnostics, Central Pathology Laboratory, St. James’s Hospital, Dublin 8, Ireland. slangabeer@stjames.ie
authors.forename: Stephen E
authors.initials: SE
authors.lastname: Langabeer
authors.forename: Karl
authors.initials: K
authors.lastname: Haslam
authors.forename: Johanna
authors.initials: J
authors.lastname: Kelly
authors.forename: Maeve
authors.initials: M
authors.lastname: Leahy
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Vandenberghe
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D005091:Exons; D017809:Fatal Outcome; D005260:Female; D016044:Fusion Proteins, bcr-abl / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D008875:Middle Aged; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism* / Q000503:physiopathology; D014178:Translocation, Genetic
chemical_list: D000970:Antineoplastic Agents; D016044:Fusion Proteins, bcr-abl